|
... The company said it had cash and money market investments of £30.8m at the end of the period versus £16.6m at the end of 2004.Chairman Sir Brian Richards said, "Alizyme has had another year of excellent progress, achieving significant milestones, and defining the potential of our development assets.""We are now well positioned to exploit the commercial value inherent in our late stage product portfolio."Related Companies:Alizyme (AZM)
Page 1 Page 2 Page 3 Finance News Headlines Future warns as sales weakenToday 08:17 Confident Waterman lifts interim profitsToday 08:13 Alizyme losses grow on R&D spend hikeToday 07:56 Greggs hit by high energy costsToday 07:48 Mapeley raises core profit over 26%Today 07:44 Marshalls profits slide in tough marketToday 07:32 Amlin boasts record profitsToday 07:05 HMV confirms new 210p Permira offerThu 17:49 Thian misses out on SkyePharma jobThu 16:14 Russian approval lifts S&NThu 15:20 Acambis posts big loss, awaits US smallpox decisionThu 14:09 Town Centre eyes 'satisfactory' yearThu 13:59 Elan resumes trading after Tysabri approvalThu 12:08 Hydrodec wins purchase orderThu 12:04 Biocompatibles sees sales improvingThu 11:50 Vislink makes strong startThu 11:45 Ark Therapeutics increases lossesThu 11:08 First Quantum enjoys record yearThu 10:49 JJB signs 10-year Rangers dealThu 10:41 Bovis gets thumbs up for Stanton CrossThu 10:37 OFT refers supermarkets over...Read more... 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news
|